ASRT
ASRT
NASDAQ · Pharmaceuticals

Assertio Holdings Inc

$13.37
-0.35 (-2.55%)
As of Mar 22, 10:44 PM ET ·
Financial Highlights (FY 2026)
Revenue
127.54M
Net Income
-22,027,162
Gross Margin
68.6%
Profit Margin
-17.3%
Rev Growth
+4.0%
D/E Ratio
0.32
Revenue & Net Income
Margin Trends
FY 2026 FY 2025 FY 2024 FY 2023
Gross Margin 68.6% 68.6% 61.1% 61.1%
Operating Margin -19.6% -17.6% 27.7% 26.1%
Profit Margin -17.3% -16.4% 24.0% 28.0%
Income Statement
FY 2026 FY 2025 FY 2024 FY 2023
Revenue 127.54M 122.60M 46.50M 50.98M
Gross Profit 87.51M 84.12M 28.43M 31.17M
Operating Income -24,985,715 -21,616,017 12.90M 13.28M
Net Income -22,027,162 -19,056,470 11.15M 14.28M
Gross Margin 68.6% 68.6% 61.1% 61.1%
Operating Margin -19.6% -17.6% 27.7% 26.1%
Profit Margin -17.3% -16.4% 24.0% 28.0%
Rev Growth +4.0% +4.0% +24.8% -5.2%
Balance Sheet
FY 2026 FY 2025 FY 2024 FY 2023
Total Debt 10.73M 10.73M 22.71M 25.70M
Total Equity 33.48M 33.48M 31.18M 30.14M
D/E Ratio 0.32 0.32 0.73 0.85
Cash Flow
FY 2026 FY 2025 FY 2024 FY 2023
EBITDA 3.97M 3.62M 17.15M 17.67M
Free Cash Flow 10.93M 11.61M